This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Ocado Group PLC | 523.1 | 3.6% |
| GSK PLC | 1,658.3 | 2.9% |
| Croda International PLC | 4,994.6 | 2.7% |
| Smith & Nephew PLC | 1,112.5 | 1.4% |
| Informa PLC | 785.2 | 1.3% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| JD Sports Fashion PLC | 107.6 | -4.8% |
| Ashtead Group PLC | 5,121.0 | -4.2% |
| Howden Joinery Group PLC | 774.6 | -3.5% |
| Airtel Africa PLC | 107.7 | -3.3% |
| Barclays PLC | 145.9 | -3.2% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,616 | -0.1% | -3.6% |
| DOW JONES INDUS. AVG | 38,654 | 0.4% | 13.9% |
| DAX INDEX | 16,918 | 0.4% | 9.3% |
| NIKKEI 225 | 36,354 | 0.5% | 32.2% |
| S&P/ASX 200 INDEX | 7,626 | -1.0% | 0.9% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 72.30 | 0.03% |
| Brent Crude (ICE) | USD/bbl. | 77.45 | 0.16% |
| Gold Spot | USD/t oz. | 2,028 | -0.6% |
| Copper (Comex) | USd/lb. | 382 | 0.0% |
Click graph to enlarge
The UK 100 called to open +54 points at 7,666. The UK 100 looks set to open higher this morning, after US markets closed above earlier lows and despite figures showing a drop in retail sales in January. Data from the BRC and KPMG showed retail sales grew by 1.2% year-on-year in January, slowing down from growth of 4.2% in January 2023. Stocks on Wall Street fell on Monday as Treasury yields spiked higher on concerns that the Federal Reserve may not cut rates as much as expected. The Dow Jones dropped 274.30 points, or 0.71%, to settle at 38,380.12. The S&P slipped 0.32% to close at 4,942.81. The Nasdaq edged down 0.2% to end at 15,597.68.
BP reported Q4 earnings of $3bn, exceeding forecasts as they increased the pace of its share repurchases. The quarterly results lifted their 2023 profit to $13.8bn, a 50% drop from a year earlier as oil and gas prices cooled and refining profit margins weakened.
GSK’s Dreamm-7 phase 3 trial shows Blenrep nearly triples survival for myeloma treatment.
Renishaw expects an improvement in trading performance in H2 as they expect their FY revenue to be in the range of £675-715m. They see their adjusted Profit Before Tax to be in the range of £122-147m.
Virgin Money report that UK Q1 customer deposits came in at £67.31bn up from £66.16bn YoY and customer lending was £72.83bn up from £72.75bn YoY. They remain “highly focused” on managing cost base and improved efficiency.
Barclays Downgrades Entain to Equal-weight from Overweight (14 Buys / 2 Holds / 0 Sells)
UK
BP
Renishaw
Virgin Money
US
Amgen
Eli Lilly and Co
Spotify Technology SA
Willis Towers Watson
Ford Motor Co
Gilead Sciences
MicroStrategy
UK
Ashmore Group
Barratt Developments
PZ Cussons
Smurfit Kappa Group
UK Commercial Property REIT
DCC PLC
US
Alibaba Group Holding
ARM Holdings
PayPal Holdings
The Walt Disney Co
Uber Technologies
UK BRC Like-For-Like Retail Sales
German Factory Orders
EU Retail Sales
UK 100 companies going ex-dividend on 8th February 2023:
None
UK 250 companies going ex-dividend on 8th February 2023:
Aberforth Smaller Companies Trust
GCP Infrastructure Investments
Bluefield Solar Income Fund
Target Healthcare REIT
Octopus Renewables Infrastructure Trust
LXi REIT
Henderson Smaller Cos Inv Tst
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.